摘要
目的:探讨内观疗法对精神分裂症患者服药依从性和复发的影响。方法:将112例精神分裂症患者随机分为内观疗法组和对照组各56例,两组均进行系统的抗精神病药物治疗和常规护理,内观疗法组在此基础上进行内观疗法。分别于治疗前、治疗3个月时及治疗1年时用自知力与治疗态度问卷量表(ITAQ)进行评定,并比较其服药依从性。观察1年了解其复发情况。结果:两组患者治疗3个月时及1年时内观疗法组的服药依从性明显优于对照组(分别为P<0.01,P<0.05)。1年内复发率内观疗法组明显低于对照组(P<0.05)。结论:内观疗法能够提高精神分裂症患者服药依从性,降低复发率。
Objective： To investigate the effects of Naikan therapy on drug compliance and recurrence in schizophrenic patients. Method：112 cases of schizophrenia were randomly divided into Naikan therapy group and control group,（56 cases in each group）,both groups accepted systematic antipsychotic treatment and conventional care.Naikan therapy group accepted Naikan therapy in addition.Drug compliance was evaluated by insight and attitude questionnaire（ITAQ） before and after treatment（3 months and 1 year）.All patients were observed for 1 year for evaluating the recurrence. Results：Naikan therapy can effectively improve the drug compliance at 3 month（P0.05） and 1 year（P0.01）.The 1 year relapse rate of Naikan therapy group was significantly lower than the control group（P0.01）. Conclusion：Naikan therapy can improve drug compliance and reduce relapse rate of schizophrenic patients.
出处
《临床精神医学杂志》
2011年第2期115-116,共2页
Journal of Clinical Psychiatry
